Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy
Open Access
- 20 February 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Human Genetics
- Vol. 52 (4), 328-333
- https://doi.org/10.1007/s10038-007-0119-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Glucocorticoid-induced alternative promoter usage for a novel 5′ variant of granzyme AJournal of Human Genetics, 2006
- Treatment of Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 2006
- No Advantage of Dexamethasone Over Prednisolone for the Outcome of Standard- and Intermediate-Risk Childhood Acute Lymphoblastic Leukemia in the Tokyo Children's Cancer Study Group L95-14 ProtocolJournal of Clinical Oncology, 2005
- Identification of novel direct transcriptional targets of glucocorticoid receptorLeukemia, 2004
- Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevanceCell Death & Differentiation, 2004
- Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 2004
- A novel mechanism for imatinib mesylate–induced cell death of BCR-ABL–positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activityBlood, 2004
- Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemiaBlood, 2003
- Granzyme A mediates glucocorticoid-induced apoptosis in leukemia cellsThe FASEB Journal, 2003
- Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2003